27.5% of patients in this study had a CRT device, and there was a nonsignificant trend toward a lower primary endpoint in this subgroup (HR 0.54; 95% confidence interval 0.28–1.04).
2
—
—
The sentences
7 There was no significant difference in mortality between the groups, and only a borderline significant trend toward fewer heart failure hospitalizations for those who received CRT.